
zzso is a new zzso zzso ) zzso zzso developed as a treatment for zzso zzso and vomiting zzso To evaluate the efficacy and safety of zzso used in combination with standard therapy zzso and zzso we conducted a zzso phase II, zzso zzso zzso study in Japanese cancer patients who received cancer chemotherapy including zzso zzso zzso zzso was administered for zzso A total of 453 patients were zzso In the three study groups, zzso standard therapy, zzso zzso zzso zzso on day 1 and zzso on days zzso and zzso zzso zzso zzso on day 1 and zzso on days zzso the percentage of patients with complete response (no zzso and no rescue zzso was zzso zzso zzso zzso zzso subjects) and zzso zzso zzso zzso This shows that efficacy was significantly higher in the zzso zzso and zzso groups than in the standard therapy group zzso test zzso testing zzso zzso and zzso zzso and highest in the zzso zzso zzso The delayed phase efficacy zzso zzso was similar to the overall phase efficacy zzso zzso indicating that zzso is effective in the delayed phase when standard therapy is not very zzso In terms of safety, zzso was generally well tolerated in Japanese cancer zzso zzso number, zzso 

